
zzso vaccination against zzso zzso represents an attractive option for cancer therapy in view of the comparatively low toxicity and, so far, excellent safety profile of this zzso Nevertheless, it is now recognized that the vaccination strategies used for zzso zzso against infectious diseases cannot necessarily be used for therapeutic cancer zzso Cancer patients are usually zzso and most zzso zzso are self zzso zzso various zzso techniques are under investigation in an effort to bolster immune systems and to overcome immune tolerance to self zzso Various strategies to stimulate zzso zzso zzso zzso and innate immune activity are under zzso Similarly, strategies to produce an zzso zzso zzso at the site of the tumor itself are under zzso as it is recognized that while zzso zzso can be activated at the site of zzso they require appropriate signals to be attracted to a zzso The zzso evaluation and zzso of specific immune responses generated by vaccination with zzso zzso is another important area of therapeutic cancer vaccine evaluation receiving much attention and novel zzso Multiple clinical trials have been undertaken to evaluate therapeutic vaccines in zzso zzso protocols such as those combining specific stimulation of zzso and chemotherapy or strategies to block immune regulation are having some zzso 

